Tag: market review
Recent Post
Mustang Bio Inc (NASDAQ: MBIO) Receives Orphan Drug Designation From US...
Mustang Bio Inc (NASDAQ: MBIO) has received an Orphan Drug Designation from the US FDA for its CD20-targeted, autologous CAR T cell therapy, MB-106,...
